Literature DB >> 28853970

Primary Care Physicians' Views about Prescribing Methadone to Treat Opioid Use Disorder.

James D Livingston1, Erica Adams2, Marlee Jordan1, Zachary MacMillan3, Ramm Hering4.   

Abstract

BACKGROUND: Methadone maintenance treatment is an effective way to reduce harms associated with opioid use disorder and, in several countries, is delivered in community-based primary care settings. Expanding methadone into primary care depends, in part, on physicians' willingness and readiness to integrate it into their practices.
OBJECTIVES: This qualitative study explores factors that primary care physicians consider important when contemplating prescribing methadone to treat opioid use disorder.
METHODS: In-depth interviews were conducted during 2015 with 20 primary care physicians in various sized communities throughout Nova Scotia, Canada. Participants shared their views and experiences related to prescribing methadone to treat opioid use disorder. Data were analyzed inductively using thematic analysis to identify predominant themes.
RESULTS: Participants discussed an interplay of factors as they contemplated prescribing methadone to treat opioid use disorder in primary care. Physician-related factors included access to methadone expertise, support from allied professionals, suitability of skills, and personal experiences. Patient-related factors involved perceptions about methadone users as a difficult patient group with highly complex needs. Practice-related factors encompassed concerns about threats to physicians' careers, surveillance duties, unfair remuneration, safety risks, and practice disruptions. Contextual factors included knowledge deficits about substance use disorders, the generalist nature of primary care, methadone's socio-political context, and opioid prescribing patterns in primary care.
CONCLUSIONS: Understanding the perspectives of physicians is vital to expanding methadone into primary care. This study identifies factors that should be addressed to attract, support, and retain primary care physicians in prescribing methadone to treat opioid use disorder.

Entities:  

Keywords:  Methadone maintenance treatment; opioid use disorder; primary care; qualitative research; stigma

Mesh:

Substances:

Year:  2017        PMID: 28853970     DOI: 10.1080/10826084.2017.1325376

Source DB:  PubMed          Journal:  Subst Use Misuse        ISSN: 1082-6084            Impact factor:   2.164


  12 in total

1.  Yonder: Chronic pain, asthma, obstructive sleep apnoea, and methadone prescribing.

Authors:  Ahmed Rashid
Journal:  Br J Gen Pract       Date:  2018-05       Impact factor: 5.386

2.  A systematic review of patients' and providers' perspectives of medications for treatment of opioid use disorder.

Authors:  Katharine Cioe; Breanne E Biondi; Rebecca Easly; Amanda Simard; Xiao Zheng; Sandra A Springer
Journal:  J Subst Abuse Treat       Date:  2020-09-22

3.  Medicaid prevalence and opioid use disorder treatment access disparities.

Authors:  Michael R Richards; Ashley A Leech; Bradley D Stein; Melinda B Buntin; Stephen W Patrick
Journal:  Health Serv Res       Date:  2021-12-18       Impact factor: 3.402

Review 4.  Improving Access to Evidence-Based Medical Treatment for Opioid Use Disorder: Strategies to Address Key Barriers within the Treatment System.

Authors:  Bertha K Madras; N Jia Ahmad; Jenny Wen; Joshua Sharfstein Sharfstein
Journal:  NAM Perspect       Date:  2020-04-27

5.  Office-based Methadone Prescribing for Opioid Use Disorder: The Canadian Model.

Authors:  Robert A Kleinman; Thomas D Brothers; Marlon Danilewitz; Anees Bahji
Journal:  J Addict Med       Date:  2022-01-11       Impact factor: 4.647

6.  Substance use disorder approaches in US primary care clinics with national reputations as workforce innovators.

Authors:  Denalee M O'Malley; Cilgy M Abraham; Heather S Lee; Ellen B Rubinstein; Jenna Howard; Shawna V Hudson; Autumn M Kieber-Emmons; Benjamin F Crabtree
Journal:  Fam Pract       Date:  2022-03-24       Impact factor: 2.290

7.  Barriers and facilitators to office-based opioid agonist therapy prescribing and effective interventions to increase provider prescribing: protocol for a systematic review.

Authors:  Lara L Nixon; Jazmin C Marlinga; K Alix Hayden; Kelly J Mrklas
Journal:  Syst Rev       Date:  2019-07-25

8.  Evaluating comparative effectiveness of psychosocial interventions adjunctive to opioid agonist therapy for opioid use disorder: A systematic review with network meta-analyses.

Authors:  Danielle Rice; Kimberly Corace; Dianna Wolfe; Leila Esmaeilisaraji; Alan Michaud; Alicia Grima; Bradley Austin; Reuben Douma; Pauline Barbeau; Claire Butler; Melanie Willows; Patricia A Poulin; Beth A Sproule; Amy Porath; Gary Garber; Sheena Taha; Gord Garner; Becky Skidmore; David Moher; Kednapa Thavorn; Brian Hutton
Journal:  PLoS One       Date:  2020-12-28       Impact factor: 3.240

9.  Retention of opioid agonist treatment prescribers across New South Wales, Australia, 2001-2018: Implications for treatment systems and potential impact on client outcomes.

Authors:  Nicola R Jones; Suzanne Nielsen; Michael Farrell; Robert Ali; Anthony Gill; Sarah Larney; Louisa Degenhardt
Journal:  Drug Alcohol Depend       Date:  2020-12-19       Impact factor: 4.492

10.  Evaluating comparative effectiveness of psychosocial interventions for persons receiving opioid agonist therapy for opioid use disorder: protocol for a systematic review.

Authors:  Danielle B Rice; Brian Hutton; Patricia Poulin; Beth A Sproule; Dianna Wolfe; David Moher; Kednapa Thavorn; Gary Garber; Sheena Taha; Amy Porath; Melanie Willows; Leila Esmaeilisaraji; Fatemeh Yazdi; Beverley Shea; Becky Skidmore; Kimberly Corace
Journal:  BMJ Open       Date:  2018-10-18       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.